Building Up A Portfolio At A 7000 Level

Status
Not open for further replies.
Hello Supratik,

We have been holding HEG for past few months, without much appreciation.
From last week, it has started downward journey!
So, do you think, it is good to hold or sell?

Thanks,
Narendra

Narendra,
I think the downside would be limited in this. It has a stable point at 155 it should not break that. I think we can use that as a SL.
Technically it looks a good script but sometimes it is not prominent in the market. I think the appreciation in the market would come after some days. I think we can sell it now (I believe we are not in a loss anyway) and once the activity starts, we can take position.

Thanks and Regards
Supratik
 
Narendra,
I think the downside would be limited in this. It has a stable point at 155 it should not break that. I think we can use that as a SL.
Technically it looks a good script but sometimes it is not prominent in the market. I think the appreciation in the market would come after some days. I think we can sell it now (I believe we are not in a loss anyway) and once the activity starts, we can take position.

Thanks and Regards
Supratik
Thanks for the quick response Supratik.
Please let me know when we can rebuy it.

Also, any new tips?

Regards,
Narendra
 
Thanks for the quick response Supratik.
Please let me know when we can rebuy it.

Also, any new tips?

Regards,
Narendra
I think Bharti Airtel is one script that I think would do well. I am bullish on this counter they have entry into Sr Lanka (refer newspaper for details). I think this is ofcourse a multibagger.
This was recommended by Outlook Money and I have posted the same in the forum. I think telecom is one sector which should do well in the next few years.

I have taken position in the script myself.

Thanks and Regards
Supratik
 
I think Bharti Airtel is one script that I think would do well. I am bullish on this counter they have entry into Sr Lanka (refer newspaper for details). I think this is ofcourse a multibagger.
This was recommended by Outlook Money and I have posted the same in the forum. I think telecom is one sector which should do well in the next few years.

I have taken position in the script myself.

Thanks and Regards
Supratik
Yes, that is a good one. I had taken it 1.5 years back when it was at Rs.220.
I sold just before the May06 crash and again bought it last month.

-Narendra
 
Updates on Deccan Chronicle

Deccan Chronicle Q3 earnings surge 52.2%
Source: IRIS (19 January 2007)

Deccan Chronicle (Q, N,C,F)* Holdings said Friday that the company`s earnings rose 52.20% for the quarter ended December 2006. During the quarter, the company`s net profit increased to Rs. 484.40 million as compared with a profit of Rs. 318.26 million in the corresponding quarter the previous year.

The sales for the quarter rose 44.03% to Rs. 1463.9 million compared with Rs 1016.38 million, a year ago.

The total income for the quarter rose 39.33% to Rs 1516.20 million compared with Rs 1088.19 million, a year ago.

The earning per share for the quarter jumped to Rs 11.34 compared with Rs 7.72 in the year ago period.

The shares of company closed down Rs 2.25, or 0.26% at Rs 857.70 at the NSE. Total volume of shares traded was 69,956 (12.27 p.m., Friday).




Recommend a hold on this counter. It should foray into Kerala - market sources and if this is true we shall buy into the couter.

Thanks and Regards
Supratik
 
Hi All,

fyi

Dr Reddy's Q3 net zooms 200% to Rs 188cr

Our Web Bureau / Mumbai January 22, 2007



Dr Reddys Laboratories (DRL) today reported a 200% increase in consolidated net profit at Rs 187.94 crore for the third quarter ended December 31, 2006 under US GAAP as against Rs 62.83 crore in Q3FY06.

According to a release issued by the company to the BSE today, total income moved up 160% to Rs 1,543.42 crore from Rs 592.63 crore in Q3FY06.

Satish Reddy, vice chairman, Dr. Reddy's Labs, said international revenue zoomed over 200% in Q3FY07.

G V Prasad, CEO, Dr. Reddy's Labs, said: "Fiscal 2007 has been a truly extraordinary year for Dr. Reddy’s in many ways. For the first time in the history of Dr. Reddy’s, we have crossed $1 billion in revenue."

Thanks and Regards
Supratik
 
Hi All,

The next tip is on IPCA Lab. CMP 620.
The target will not be set currently. Buy in low volumes – it is highly volatile and we may need to buy again at lower levels (to average it out).
This tip is little on the higher risk side.


Results update:
Related Links
Ipca Laboratories Limited
Ipca Labs net up 12.05 times in Dec`06 qtr
Source: IRIS (23 January 2007)

Ipca Labs (Q, N,C,F)* reported a substantial jump of 12.05 times in net profits to Rs. 348.4 million for quarter ending December 2006 as compared to Rs. 26.7 million for quarter ended December 2005.

Net sales for the quarter rose 34.61% to Rs. 2324.9 million compared with the corresponding quarter, a year ago.

Total Income (net of excise) has increased 33.48% to Rs 2330.5 million as against Rs 1745.9 million in same quarter last year.

Earnings per share for the quarter rose to Rs 13.94 from Rs 1.07 last year.

Ipca is a Mumbai based fast growing fully integrated pharmaceutical company engaged in the manufacturing and marketing of a range of pharmaceuticals world over with a strong thrust on exports.

On Jan. 2, 2007, the Ipca - Ranbaxy alliance received USFDA marketing approval for Atenolol Tablets. It is one of the largest producers in the world of API Atenolol and holds its DMFs in various countries. Ipca is also marketing formulations of Atenolol in various markets such as CIS, Asia, Africa and Europe. This approval will further strengthen Ipca`s global market share of this product.

Will this be Divi's Lab?????

Thanks and Regards
Supratik
 
Last edited:
Hi All,

Heard on the Streets call on S…..P – guess it – will post it tomorrow – stress your brain for the night:)

Please note: Heard on the streets call is only a punter pick and may not be on the fundamental story of the company.

Thanks and Regards
Supratik
 
Status
Not open for further replies.

Similar threads